메뉴 건너뛰기




Volumn 7, Issue SUPPL. 1, 2006, Pages

Targeting hypertension with Valsartan: Lessons learned from the Valsartan/HCTZ versus amlodipine in stage II hypertensive patients (VAST) trial

Author keywords

Hydrochlorothiazide; Hypertension; Valsartan; VAST trial

Indexed keywords

AMLODIPINE; DIURETIC AGENT; HYDROCHLOROTHIAZIDE PLUS VALSARTAN;

EID: 33748665219     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2006.020     Document Type: Article
Times cited : (4)

References (20)
  • 1
    • 0347423198 scopus 로고    scopus 로고
    • Seventh report of the joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    • Chobanian AV, Bakris GL, Black HR et al. Seventh report of the joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
    • (2003) Hypertension , vol.42 , pp. 1206-1252
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3
  • 2
    • 0037527647 scopus 로고    scopus 로고
    • 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension
    • European Society of Hypertension-European Society of Cardiology Guidelines Committee
    • European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
    • (2003) J Hypertens , vol.21 , pp. 1011-1053
  • 3
    • 0344718782 scopus 로고    scopus 로고
    • 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
    • World Health Organization, International Society of Hypertension Writing Group
    • Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.
    • (2003) J Hypertens , vol.21 , pp. 1983-1992
    • Whitworth, J.A.1
  • 4
    • 1542432170 scopus 로고    scopus 로고
    • Guidelines for management of hypertension: Report of the fourth working party of the British Hypertension Society, 2004 - BHS IV
    • Williams B, Poulter NR, Brown MJ et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004 - BHS IV. J Hum Hypertens 2004;18:139-85.
    • (2004) J Hum Hypertens , vol.18 , pp. 139-185
    • Williams, B.1    Poulter, N.R.2    Brown, M.J.3
  • 6
    • 0034181905 scopus 로고    scopus 로고
    • Clinical Advisory Statement: Importance of systolic blood pressure in older Americans
    • Izzo JL Jr, Levy D, Black HR. Clinical Advisory Statement: importance of systolic blood pressure in older Americans. Hypertension 2000;35:1021-4.
    • (2000) Hypertension , vol.35 , pp. 1021-1024
    • Izzo Jr., J.L.1    Levy, D.2    Black, H.R.3
  • 7
    • 0036303674 scopus 로고    scopus 로고
    • Systolic hypertension as a cardiovascular risk factor
    • McInnes GT. Systolic hypertension as a cardiovascular risk factor. Blood Press 2002;11:134-43.
    • (2002) Blood Press , vol.11 , pp. 134-143
    • McInnes, G.T.1
  • 8
    • 1042302784 scopus 로고    scopus 로고
    • Hypertension management in adults with diabetes. Position Statement
    • American Diabetes Association. American Diabetes Association
    • American Diabetes Association. Hypertension management in adults with diabetes. Position Statement. American Diabetes Association. Diabetes Care 2004;27:S65-S67.
    • (2004) Diabetes Care , vol.27
  • 10
    • 0038690424 scopus 로고    scopus 로고
    • Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000
    • Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
    • (2003) JAMA , vol.290 , pp. 199-206
    • Hajjar, I.1    Kotchen, T.A.2
  • 11
    • 9144248446 scopus 로고    scopus 로고
    • Hypertension treatment and control in five European countries, Canada, and the United States
    • Wolf-Maier K, Cooper RS, Kramer H et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-17.
    • (2004) Hypertension , vol.43 , pp. 10-17
    • Wolf-Maier, K.1    Cooper, R.S.2    Kramer, H.3
  • 12
    • 0032031731 scopus 로고    scopus 로고
    • Managing the patient with hard-to-control hypertension
    • Oparil S, Calhoun D. Managing the patient with hard-to-control hypertension. Am Fam Phys 1998;57:1007-20.
    • (1998) Am Fam Phys , vol.57 , pp. 1007-1020
    • Oparil, S.1    Calhoun, D.2
  • 13
    • 33644806751 scopus 로고    scopus 로고
    • Expanding the definition and classification of hypertension
    • Giles TD, Berk BC, Black HR et al. Expanding the definition and classification of hypertension. J Clin Hypertens 2005;7:505-12.
    • (2005) J Clin Hypertens , vol.7 , pp. 505-512
    • Giles, T.D.1    Berk, B.C.2    Black, H.R.3
  • 14
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3
  • 15
    • 20644459919 scopus 로고    scopus 로고
    • Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: The VAST study
    • Ruilope LM, Malacco E, Khder Y, Kandra A, Bonner G, Heintz D. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Clin Ther 2005;27:578-87.
    • (2005) Clin Ther , vol.27 , pp. 578-587
    • Ruilope, L.M.1    Malacco, E.2    Khder, Y.3    Kandra, A.4    Bonner, G.5    Heintz, D.6
  • 16
    • 0037396492 scopus 로고    scopus 로고
    • Endothelial dysfunction and cardiovascular disease: The promise of blocking the renin-angiotensin system
    • Erhardt LR. Endothelial dysfunction and cardiovascular disease: the promise of blocking the renin-angiotensin system. Int J Clin Pract 2003;57:211-18.
    • (2003) Int J Clin Pract , vol.57 , pp. 211-218
    • Erhardt, L.R.1
  • 18
    • 1242272037 scopus 로고    scopus 로고
    • Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis
    • Lowe GD, Danesh J, Lewington S etal. Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J 2004;25:252-9.
    • (2004) Eur Heart J , vol.25 , pp. 252-259
    • Lowe, G.D.1    Danesh, J.2    Lewington, S.3
  • 19
    • 0347625841 scopus 로고    scopus 로고
    • Blood pressure, C reactive protein and risk of future cardiovascular events
    • Blake GJ, Rifai N, Buring JE, Ridker PM. Blood pressure, C reactive protein and risk of future cardiovascular events. Circulation 2003;108:2993-9.
    • (2003) Circulation , vol.108 , pp. 2993-2999
    • Blake, G.J.1    Rifai, N.2    Buring, J.E.3    Ridker, P.M.4
  • 20
    • 0042665536 scopus 로고    scopus 로고
    • Metabolic syndrome with and without C reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study
    • Sattar N, Gaw A, Scherbakova O et al. Metabolic syndrome with and without C reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108:414-19.
    • (2003) Circulation , vol.108 , pp. 414-419
    • Sattar, N.1    Gaw, A.2    Scherbakova, O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.